incorporating regorafenib in the hcc treatment landscape
Published 7 years ago • 493 plays • Length 8:29Download video MP4
Download video MP3
Similar videos
-
1:03
dr. musher discusses the role of regorafenib in advanced hcc
-
7:01
global use of regorafenib in hcc
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
3:48
clinical experience with regorafenib in hcc
-
1:27
dr. sherman on the role of regorafenib in liver cancer
-
7:46
clinical use of regorafenib in mhcc
-
2:00
advances in the treatment landscape of hcc
-
3:11
regorafenib in advanced hcc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
2:02
dr. bruix discusses the application of regorafenib in hcc
-
2:52
refine: a real-world analysis of regorafenib in patients with unresectable hcc
-
4:30
regorafenib following first-line systemic therapy in hcc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
2:04
dr. bruix on regorafenib in second-line hcc
-
1:11
regorafenib vs sorafenib in the treatment of liver cancer
-
7:09
global use of regorafenib in hcc
-
0:49
dr. bendell on remaining questions with regorafenib in hcc
-
4:32
first-line regorafenib 80mg/day with pembrolizumab in advanced hcc